Casgevy Interactions
There are 95 drugs known to interact with Casgevy (exagamglogene autotemcel), along with 4 disease interactions. Of the total drug interactions, 33 are major, and 62 are moderate.
- View all 95 medications that may interact with Casgevy
- View Casgevy disease interactions (4)
Most frequently checked interactions
View interaction reports for Casgevy (exagamglogene autotemcel) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Calquence (acalabrutinib)
Casgevy disease interactions
There are 4 disease interactions with Casgevy (exagamglogene autotemcel) which include:
Report options
More about Casgevy (exagamglogene autotemcel)
- Casgevy consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Zynteglo
Zynteglo (betibeglogene autotemcel) is a gene therapy indicated for the treatment of patients with ...
Oxbryta
Oxbryta (voxelotor) is used for the treatment of patients with sickle cell disease (SCD). Oxbryta ...
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Lyfgenia
Lyfgenia (lovotibeglogene autotemcel) is a gene therapy that uses a viral vector and is given as a ...
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Adakveo
Adakveo (crizanlizumab-tmca) is used for the prevention of vasoocclusive crises (VOCs) in patients ...
Glutamine
Glutamine systemic is used for dietary supplementation, short bowel syndrome, sickle cell anemia
Lovotibeglogene autotemcel
Lovotibeglogene autotemcel systemic is used for sickle cell disease
Betibeglogene autotemcel
Betibeglogene autotemcel systemic is used for beta thalassemia
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.